as on February 11, 2026 at 9:31 pm IST
Day's Low
Day's High
0.01%
Downside
3.09%
Upside
52 Week's Low
52 Week's High
8.59%
Downside
21.22%
Upside
as on February 11, 2026 at 4:01 pm IST
Market Cap
₹96.62 Cr
Return on Equity (ROE)
6.01
PE Ratio (TTM)
0Return on capital employed (ROCE)
8.98
Beta (LTM)
0.54
P/B Ratio
1.83
Dividend Yield
0PEG Ratio
0Quarterly Earnings Growth YOY
-15.97
EPS (TTM)
0Sector
Pharmaceuticals
Book Value
0Technical Analysis
Bearish
View Technical Analysis
Compare market cap, revenue, PE, and other key metrics of Mercury Labs with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 96.62 | 3.46% | 0.00 | 3 | 75 | |
| NA | 38.06 | 70.62% | 0.00 | 1 | 16 | |
| NA | 70.26 | 0.51% | 0.00 | 7 | 50 | |
| NA | 915.78 | 90.54% | 0.51 | 18 | 156 | |
| NA | 25.91 | -17.84% | 0.00 | 2 | 22 |
Get share price movements and forecasts by analysts on Mercury Labs.
Source: S&P Global Market Intelligence
Search interest for Mercury Laboratories Ltd Stock has increased by 74% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:74% versus previous 30 day period
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Mercury Labs.
Mercury Laboratories Ltd’s net profit jumped 228% since last year same period to ₹1.64Cr in the Q2 2025-2026. On a quarterly growth basis, Mercury Laboratories Ltd has generated 69.07% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2025, Mercury Laboratories Ltd has declared dividend of ₹3.50 per share on 14 May 2025 - translating a dividend yield of 0.87%.
Read More about DividendsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 7 days, Mercury Labs stock has moved up by 2.6%
Retail Holding Unchanged
![]()
Retail Investor holdings remained unchanged at 26.34% of holdings in Dec 2025 quarter
Against Peers
![]()
In the last 3 years, Torrent Pharmaceuticals Ltd has given 167.8% return, outperforming this stock by 169.5%
Against Peers
![]()
In the last 1 year, Torrent Pharmaceuticals Ltd has given 32.6% return, outperforming this stock by 38.0%
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 73.66% of holdings in Dec 2025 quarter
| Organisation | Mercury Laboratories Ltd |
| Headquarters | Vadodara |
| Industry | Pharmaceuticals |
| CEO | Divyakant Ramniklal Zaveri |
| E-voting on shares | Click here to vote |
Mercury Labs share price today stands at ₹805.15 as on . Mercury Labs share today touched a day high of ₹830 and a low of ₹805.1.
Mercury Labs touched a 52 week high of ₹976 and a 52 week low of ₹736. Mercury Labs share price today i.e. is trending at ₹805.15, which is -17.51% down from its 52 week high and 9.40% up from its 52 week low.
Mercury Labs market capitalisation is ₹96.62 Cr as on .
To buy Mercury Labs shares, you need to follow these steps:
Mercury Labs trading volume is 26.00 as on . This means that 26.00 shares of Mercury Labs were bought and sold on the stock market during today's trading session.